VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

VOICES

Explore our FDA-focused solution areas to see how we support medical device and pharmaceutical companies across regulatory pathways and product types, from early strategy through approval-ready submissions.

BSC® Insights

Why are inclusion criteria important?

Insights

2 min read time

Some of the reasons why inclusion criteria are important

Participant Safety: Inclusion criteria help identify individuals suitable for the study without undue risk. Excluding certain populations, such as those with pre-existing medical conditions or contraindications to the intervention, reduces the likelihood of adverse events and ensures the safety of participants.

Homogeneity of Study Population: Researchers can create a more homogenous study population by defining clear inclusion criteria. This reduces potential confounding factors and allows more accurate and meaningful comparisons between treatment groups.

Validity of Study Results: Inclusion criteria ensure that participants have the condition or characteristics relevant to the research question being studied. Including only individuals with a specific medical condition or risk factor helps ensure that the study results apply to the intended target population.

Feasibility of the Study: Clearly defined inclusion criteria help researchers identify eligible participants efficiently. This improves the recruitment process and reduces the risk of enrolling individuals who do not meet the study's objectives.

Ethical Considerations: Inclusion criteria are essential to protecting participants' rights and ensuring ethical conduct in clinical research. They prevent the enrollment of vulnerable populations, such as pregnant women, children, or individuals unable to provide informed consent, inappropriately.

Regulatory Requirements: Regulatory bodies, such as the FDA and EMA, require well-defined inclusion criteria for the clinical trial protocol. Meeting these requirements is necessary for obtaining regulatory approval for new medical treatments.

Generalizability of Results: By carefully defining the study population through inclusion criteria, researchers can draw more accurate conclusions about the potential effectiveness and safety of the intervention for the target population.

Summary

In summary, inclusion criteria in clinical trials are vital for selecting appropriate participants, ensuring participant safety, producing valid and reliable results, and adhering to ethical and regulatory standards. Well-defined and appropriate inclusion criteria contribute to the success and credibility of clinical trials.

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

BSC®

Get regulatory insights

that help you work smarter.

Receive updates on clinical trial methodology, regulatory developments, FDA guidance, and practical biostatistical insights drawn from real-world experience.

By proceeding, you agree to our Privacy Policy

Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®
Biomedical Statistical Consulting®

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.

Request Expert Review

Backed by Regulatory Experience.

Engage directly with senior biostatisticians to review your clinical strategy, statistical approach, or FDA submission — with clarity, rigor, and regulatory perspective.

Confidential discussion with senior biostatisticians experienced in FDA submissions.